MediPrint™ Ophthalmics Announces Promising Results From Its Primary Market Research
Plus, Company Receives Patent for Novel Post-Cataract Surgery Lens SAN
MediPrint featured in Review of Optometry
The Coming Rise of Drug-delivery Contact Lenses This novel new
MediPrint™ Ophthalmics Announces New Corporate Branding and New Website
Plus, Company Spotlights its Successful First-in-human Clinical Study Results
MediPrint™ Ophthalmics Announces Successful Completion of Its SIGHT-1 Phase 2a Clinical Study
First-in-human Trial with Novel Glaucoma Treatment Confirmed Favorable Safety
Leo Lens Pharma Achieves Two Significant Milestones – FDA IND Submission and Seed Round Fundraising Success
IND Paves the Way to Phase 2a Clinical Study
Leo Lens Pharma Expands Its Scientific Advisory Board
External Thought Leaders to Help Guide Progress on Company’s
Leo Lens Pharma Excited to Have Its Lead Asset Ready for Human Clinical Evaluation
Patented product for the novel treatment of glaucoma is